Reports for PFIZER CANADA ULC
Company Name
PFIZER CANADA ULC
Totals |
||
Shortage reports |
759 |
|
Actual shortage: | 83 (11%) | |
Anticipated shortage: | 9 (1%) | |
Avoided shortage: | 49 (6%) | |
Resolved: | 618 (81%) | |
Discontinuation Reports |
87 |
|
To be discontinued: | 1 (1%) | |
Discontinued: | 85 (98%) | |
Reversed: | 1 (1%) | |
Late reports |
20 (2%) |
|
Overdue reports |
10 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DIFLUCAN | 2MG | SOLUTION | Resolved | 2021-07-08 | 2021-07-27 | 142010 |
DIFLUCAN | 2MG | SOLUTION | Resolved | 2021-08-26 | 2021-10-22 | 144626 |
DIFLUCAN | 50MG | POWDER FOR SOLUTION | Resolved | 2017-04-18 | 2017-04-25 | 7210 |
DOBUTAMINE INJECTION USP | 12.5MG | SOLUTION | Resolved | 2017-10-13 | 2018-09-08 | 25930 |
DOCETAXEL INJECTION USP | 10.0MG | SOLUTION | Resolved | 2018-06-18 | 2018-08-23 | 52568 |
DOCETAXEL INJECTION USP | 10.0MG | SOLUTION | Resolved | 2018-06-18 | 2018-08-22 | 52573 |
DOCETAXEL INJECTION USP | 10.0MG | SOLUTION | Resolved | 2018-06-29 | 2018-08-23 | 53315 |
DOCETAXEL INJECTION USP | 10.0MG | SOLUTION | Resolved | 2019-11-11 | 2019-12-17 | 98444 |
DOCETAXEL INJECTION USP | 10.0MG | SOLUTION | Resolved | 2020-01-20 | 2020-03-05 | 103614 |
DOCETAXEL INJECTION USP | 10.0MG | SOLUTION | Resolved | 2020-03-06 | 2020-03-27 | 107943 |
DOCETAXEL INJECTION USP | 10MG | SOLUTION | Resolved | 2024-03-22 | 2024-04-26 | 223128 |
DOSTINEX | 0.5MG | TABLET / TABLETTE | Resolved | 2017-03-13 | 2017-04-28 | 2039 |
DOSTINEX | 0.5MG | TABLET | Resolved | 2018-03-05 | 2018-03-08 | 41789 |
DOSTINEX | 0.5MG | TABLET | Resolved | 2018-11-06 | 2018-11-22 | 66323 |
DOSTINEX | 0.5MG | TABLET | Resolved | 2018-11-26 | 2018-12-21 | 67675 |
DOSTINEX | 0.5MG | TABLET | Resolved | 2019-01-25 | 2019-09-10 | 73569 |
DOSTINEX | 0.5MG | TABLET | Resolved | 2019-10-09 | 2019-12-21 | 95815 |
DOXORUBICIN | 2MG | SOLUTION | Resolved | 2018-02-21 | 2019-05-02 | 40515 |
DOXORUBICIN | 2MG | SOLUTION | Resolved | 2023-07-26 | 2023-09-12 | 200032 |
DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP | 50MG | POWDER FOR SOLUTION | Resolved | 2023-07-20 | 2023-09-14 | 199246 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
VIRACEPT | 625MG | TABLET TABLET | Discontinued | 2021-09-03 | 2021-10-29 | 145167 |
VIRACEPT -250MG | 250MG | TABLET | Discontinued | 2021-09-03 | 2022-05-30 | 145163 |
VIZIMPRO | 15MG | TABLET | Discontinued | 2023-01-13 | 2023-01-14 | 180950 |
VIZIMPRO | 30MG | TABLET | Discontinued | 2023-01-13 | 2023-01-14 | 180953 |
VIZIMPRO | 45MG | TABLET | Discontinued | 2023-01-13 | 2023-01-14 | 180956 |
ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2021-04-16 | 2021-04-17 | 137600 |
ZYVOXAM 600 MG | 600MG | TABLET | Discontinued | 2020-01-17 | 2022-01-17 | 103480 |